OVERVIEW

Personalizing the Care of Patients with Psoriatic Arthritis - Factors Influencing Treatment Selection is organized by CME Outfitters, LLC and will be held from Nov 07, 2018 - Nov 07, 2019.

Target Audience
Rheumatologists, dermatologists, physicians, physician assistants, nurse practitioners, nurses, and pharmacists who treat patients with psoriatic arthritis.

Credit Information
CME Credit (Physicians):
USF Health designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Statement of Need
Psoriatic arthritis (PsA) negatively impacts relationships, activities of daily living, work productivity, and overall quality of life. Despite the availability of effective agents for PsA, many patient with moderate-to-severe PsA are not able to achieve optimal outcomes, and often medications used to treat PsA can exacerbate other conditions.

Fortunately, the range of current treatments for PsA is expanding, with considerable ongoing research and possibilities for improved patient care. Treatment options include non-steroidal anti-inflammatory drugs (NSAIDs) and disease-modifying antirheumatic drugs (DMARDs; conventional, biological, and target agents).

Clinicians should be choosing agents based on what the phenotype of disease is, but with consideration to comorbidities. In this CME Outfitters CME Snack, expert faculty discuss and safety of agents used in treating PsA, taking patients' comorbidities into account.

Learning Objectives
At the end of this CE activity, participants should be able to:
• Develop individualized treatment plans for patients with psoriatic arthritis that weigh the risks and benefits of newer agents.

Additional details will be posted as soon as they are available.